Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

(2009) Seok Jin Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009

(2009) Yok-Lam Kwong et al.   LANCET ONCOLOGY

Extranodal NK/T-cell lymphoma nasal type: Efficacy of pegaspargase. Report of two patients from the United Sates and review of literature

(2009) Vincent Edgar Reyes et al.   LEUKEMIA RESEARCH

L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type

(2008) Weiben Yong et al.   ANNALS OF HEMATOLOGY

Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone

(2008) B.-S. Kim et al.   ANNALS OF ONCOLOGY

L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature

(2008) A. Jaccard et al.   ANNALS OF ONCOLOGY

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

(2008) W.-y. Au et al.   BLOOD

Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia

(2008) Motoko Yamaguchi et al.   CANCER SCIENCE